Optimizing the design and in vitro evaluation of bioreactive glucose oxidase-microspheres for enhanced cytotoxicity against multidrug resistant breast cancer cells

Colloids and Surfaces B: Biointerfaces

Volumn 130, Issue , 2015, Pages 164-172

  Cheng, Ji ^a   Liu, Qun ^a   Shuhendler, Adam J ^a   Rauth, Andrew M ^a   Wu, Xiao Yu ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bioreactivity; Cell membrane damage; Cytotoxicity; Glucose oxidase encapsulated chitosan alginate microspheres; Multidrug resistant cancer cells; Optimizing design

Indexed keywords

CELL CULTURE; CELL MEMBRANES; CHITIN; CHITOSAN; COATINGS; CYTOLOGY; CYTOTOXICITY; DESIGN; DISEASES; EMULSIFICATION; GELATION; GLUCOSE; GLUCOSE OXIDASE; GLUCOSE SENSORS; LIPIDS; MICROSPHERES; MOBILE SECURITY; OXIDATION; PARTICLE SIZE;

BIOREACTIVITY; CELL MEMBRANE DAMAGES; CHITOSAN ALGINATES; MULTIDRUG-RESISTANT CANCER CELLS; OPTIMIZING DESIGN;

CELLS;

CHITOSAN; GLUCOSE OXIDASE; MICROSPHERE; REACTIVE OXYGEN METABOLITE; EMULSION; GEL; HYDROGEN PEROXIDE;

ADSORPTION; ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER CELL LINE; CELL DAMAGE; CELL MEDIATED CYTOTOXICITY; CELL TRANSPORT; CONCENTRATION (PARAMETERS); CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG FORMULATION; EMULSION; ENCAPSULATION; FLUORESCENCE ANALYSIS; GELATION; IN VITRO STUDY; INCUBATION TIME; LIPID PEROXIDATION; MATERIAL COATING; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; BREAST TUMOR; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; GEL; HUMAN; METABOLISM; PATHOLOGY; PRECLINICAL STUDY; TUMOR CELL LINE;

MURINAE;

ADSORPTION; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EMULSIONS; GELS; GLUCOSE OXIDASE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MICROSCOPY, CONFOCAL; MICROSPHERES; PARTICLE SIZE; REACTIVE OXYGEN SPECIES;

EID: 84930180206     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.04.002     Document Type: Article

References (49)

1. Higgins C.F. Nature 2007, 446:749.
2. Wong H.L., Wu X.Y., Bendayan R. Pharmaceutical Perspectives of Cancer Therapeutics 2009, 121-148. Springer, New York, USA. Y. Lu, R.I. Mahato (Eds.).
3. Ozben T. FEBS Lett. 2006, 580:2903.
4. Liu Z., Bendayan R., Wu X.Y. J. Pharm. Pharmacol. 2001, 53:779.
5. Liu Z., Bendayan R., Wu X.Y. J. Pharm. Sci. 1999, 88:412.
6. Wong H.L., Bendayan R., Rauth A.M., Wu X.Y. J. Control. Release 2006, 116:275.
7. Wong H.L., Rauth A.M., Bendayan R., Manias J.L., Ramaswamy M., Liu Z., Erhan S.Z., Wu X.Y. Pharm. Res. 2006, 23:1574.
8. Shuhendler A.J., Cheung R.Y., Manias J., Connor A., Rauth A.M., Wu X.Y. Breast Cancer Res. Treat. 2010, 119:255.
9. Coley H.M. Methods Mol. Biol. 2010, 596:341.
10. Prasad P., Cheng J., Shuhendler A.J., Rauth A.M., Wu X.Y. Drug Deliv. Transl. Res. 2012, 2:95.
11. Shuhendler A.J., Prasad P., Zhang R.X., Amini M., Sun M., Liu P., Bristow R.G., Rauth A.M., Wu X.Y. Mol. Pharm. 2014, 11:2659.
12. Calcabrini A., Arancia G., Marra M., Crateri P., Befani O., Martone A., Agostinelli E. J. Cancer 2002, 99:43.
13. Lord-Fontaine S., Agostinelli E., Przybytkowski E., Averill-Bates D.A. Biochem. Cell Biol. 2001, 79:165.
14. Agostinelli E., Tempera G., Viceconte N., Saccoccio S., Battaglia V., Grancara S., Toninello A., Stevanato R. Amino Acids 2010, 38:353.
15. Liu Q., Shuhendler A., Cheng J., Rauth A.M., O'Brien P., Wu X.Y. Breast Cancer Res. Treat. 2010, 121:323.
16. Cai Y., Lu J., Miao Z., Lin L., Ding J. Cancer Biol. Ther. 2007, 6:1794.
17. Averill-Bates D.A., Ke Q., Tanel A., Roy J., Fortier G., Agostinelli E. Int. J. Oncol. 2008, 32:79.
18. Agostinelli E., Condello M., Tempera G., Macone A., Bozzuto G., Ohkubo S., Calcabrini A., Arancia G.G., Molinari A. Int. J. Oncol. 2014, 45:1109.
19. Pelicano H., Carney D., Huang P. Drug Resist. Updates 2004, 7:97.
20. Fruehauf J.P., Meyskens F.L. Clin. Cancer Res. 2007, 13:789.
21. Lopez-Lazaro M. Cancer Lett. 2007, 252:1.
22. Cabello C.M., Bair W.B., Wondrak G.T. Curr. Opin. Investig. Drugs 2007, 8:1022.
23. Verrax J., Taper H., Calderon P.B. Curr. Mol. Pharmacol. 2008, 1:80.
24. Trachootham D., Alexandre J., Huang P. Nat. Rev. Drug Discov. 2009, 8:579.
25. Nogueira V., Hay N. Clin. Cancer Res. 2013, 19:4309.
26. Gorrini C., Harris I.S., Mak T.W. Nat. Rev. Drug Discov. 2013, 12:931.
27. Glasauer A., Chandel N.S. Biochem. Pharmacol. 2014, 92:90.
28. Wartenberg M., Ling F.C., Schallenberg M., Bäumer A.T., Petrat K., Hescheler J., Sauer H. J. Biol. Chem. 2001, 276:17420.
29. Li L., Xu J., Min T., Huang W. Redox Rep. 2006, 11:173.
30. Wartenberg M., Fischer K., Hescheler J., Sauer H. Int. J. Cancer 2000, 85:267.
31. Liu Q., Rauth A.M., Wu X.Y. Int. J. Pharm. 2007, 339:148.
32. Liu Q., Rauth A.M., Liu J., Babakhanian K., Wang X., Bendayan R., Wu X.Y. Pharm. Res. 2009, 26:2343.
33. Abdekhodaie M.J., Cheng J., Wu X.Y. Chem. Eng. Sci. 2014, 125:4. 10.1016/j.ces.2014.11.10.
34. Halliwell B., Gutteridge J.M. Lancet 1984, 2:1095.
35. Roots R., Okada S. Radiat. Res. 1975, 64:306.
36. Legrand C., Bour J.M., Jacob C., Capiaumont J., Martial A., Marc A., Wudtke M., Kretzmer G., Demangel C., Duval D., Hache J. J. Biotechnol. 1992, 25:231.
37. Smith M.T., Thor H., Hartizell P., Orrenius S. Biochem. Pharmacol. 1982, 31:19.
38. Dreher D., Junod A.F. Eur. J. Cancer 1996, 32A:30.
39. Carver L.A., Schnitzer J.F., Anderson R.G., Mohla S. Cancer Res. 2003, 63:6571.
40. Hendrich A.B., Michalak K. Curr. Drug Targets 2003, 4:23.
41. Lavie Y., Cao H., Bursten S.L., Giuliano A.E., Cabot M.C. J. Biol. Chem. 1996, 271:19530.
42. Huang X.Z., Wang J., Huang C., Chen Y.Y., Shi G.Y., Hu Q.S., Yi J. Cancer Biol. Ther. 2008, 7:468.
43. Mannechez A., Reungpatthanaphong P., de Certaines J.D., Leray G., Le Moyec L. Cancer Cell. Int. 2005, 5:2.
44. Liu Y.Y., Han T.Y., Yu J.Y., Bitterman A., Le A., Giuliano A.E., Cabot M.C. J. Lipid Res. 2004, 45:933.
45. Peetlaa C., Vijayaraghavalua S., Labhasetwar V. Adv. Drug Deliv. Rev. 2013, 65:1686.
46. Tanel A., Pallepati P., Bettaieb A., Morin P., Averill-Bates D.A. Biochim. Biophys. Acta 2014, 1843:827.
47. Choi A.O., Cho S.J., Desbarats J., Lovrić J., Maysinger D. J. Nanobiotechnol. 2007, 5:1.
48. Desai M.P., Labhasetwar V., Walter E., Levy R.J., Amidon G.L. Pharm. Res. 1997, 14:1568.
49. Koval M., Preiter K., Adles C., Stahl P.D., Steinberg T.H. Exp. Cell Res. 1998, 242:265.